Pay in 4 interest-free payments of $5.55 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Scot Roberts, PhD, Chief Scientific Officer Number Of Employees: ~57 Stage: Publicly traded Financial Snapshot: The companys market cap as of July 2026 was $548 million
Trade-off: Racetams = modest, reversible
In addition to supplements created to mimic the effects of drugs like Ozempic, there is also a growing segment of products to support users of GLP-1 medications, both in the supplement space and in grocery aisles
Patients receive shipments directly without insurance requirements or membership fees, making treatment accessible regardless of provincial health coverage policies
US$ 23.23
US$ 20.55
US$ 23.26
US$ 26.31
